Roflumilast to Treat Cognitive Sequela After Stroke

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions

Cerebrovascular DisordersMemoryFunctional RecoveryDrug Intervention

Interventions

DRUG

Roflumilast Oral Tablet

Once daily for 12 weeks

Trial Locations (1)

Maastricht University, Maastricht

All Listed Sponsors

collaborator

Netherlands Brain Foundation

OTHER

lead

Maastricht University

OTHER